![](https://themiamientrepreneur.com/wp-content/uploads/2024/07/107405227-1713892869713-gettyimages-1880595297-BRISTOL_MYERS_SQUIBB-pf6GrI-scaled.jpeg)
Bristol Myers Squibb beats earnings estimates, raises outlook as drugmaker slashes costs
The results come as Bristol Myers moves to cut $1.5 billion in costs by 2025 and reinvest that money into key drug brands and research and development programs.